Invacare Corporation
Invacare Corporation (IVC) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ivc · stock forecast · 6 analysts (3M) · FMP · updated Dec 4, 2023
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.66
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.69 | ↑ 5.00% |
1-day model range: $0.68–$0.71. Peak: $0.71 (+5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IVC · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2022-06-21 | EF Hutton | Maintains | Buy→Buy |
| 2021-10-29 | Oppenheimer | Maintains | Outperform→Outperform |
| 2021-09-10 | Needham | Maintains | Buy→Buy |
| 2021-08-19 | Oppenheimer | Maintains | Outperform→Outperform |
| 2020-03-23 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2018-08-16 | KeyBanc | Downgrade ↓ | Overweight→Equal Weight |
| 2018-05-09 | KeyBanc | Maintains | Overweight→Overweight |
| 2018-02-09 | KeyBanc | Maintains | Overweight→Overweight |
| 2017-04-28 | Stephens & Co. | Upgrade ↑ | Equal Weight→Overweight |
| 2013-09-24 | CJS Securities | Maintains | Market Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Invacare Corporation (IVC) stock. Of the recent 10 rating actions, 1 were upgrades and 1 were downgrades. 6 analysts currently cover IVC.
Analyst Recommendation Trends
IVC analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast IVC EPS of $— for the current fiscal year, based on estimates from 0 analysts. The IVC revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The IVC stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus IVC price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The IVC short-term stock prediction for tomorrow is $0.69 (+5.00%).
Invacare Corporation trades on NYSE under the ticker IVC. The IVC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 83% of covering analysts.
Frequently asked questions
IVC forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month IVC price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $0.66.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.